@article{a3cee91c6fd64fe68b403699c719e479,
title = "A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y12 Inhibitor Elinogrel Versus Clopidogrel in Patients Undergoing Nonurgent Percutaneous Coronary Intervention The INNOVATE-PCI Trial",
keywords = "Antiplatelets, Cardiovascular pharmacology, Catheter based coronary interventions, Chronic ischemic heart disease, Platelet function inhibitors",
author = "{INNOVATE-PEI Investigators} and Welsh, {Robert C.} and Rao, {Sunil V.} and Uwe Zeymer and Thompson, {Vivian P.} and Kurt Huber and Janusz Kochman and McClure, {Matthew W.} and Gretler, {Daniel D.} and Bhatt, {Deepak L.} and Gibson, {C. Michael} and Angiolillo, {Dominick J.} and Gurbel, {Paul A.} and Berdan, {Lisa G.} and Gayle Paynter and Sergio Leonardi and Mina Madan and French, {William J.} and Harrington, {Robert A.} and Martin Edelman",
year = "2012",
month = jun,
doi = "10.1161/CIRCINTERVENTIONS.111.964197",
language = "English",
volume = "5",
pages = "336--346",
journal = "Circulation: Cardiovascular Interventions",
issn = "1941-7640",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "3",
}